title: The integrin specificity of human recombinant osteopontin.
abstract: The ability of full-length human recombinant osteopontin (OPN) to support the adhesion of various alphav integrin-expressing cell lines was determined in order to characterize its integrin selectivity. The identity of this protein was assessed by cDNA sequence and mass spectroscopic analysis, and confirmed as full-length OPN. Neither the human embryonic kidney 293 cell line, which expresses the alphavbeta1 integrin, nor the human colonic adenocarcinoma HT-29 cell line, which expresses the alphavbeta5 integrin, were able to adhere to OPN; both of these cell lines are deficient in the beta3 subunit. In contrast, an alphavbeta3 integrin-expressing cell line, SK-MEL-24, was able to adhere to OPN in an arginine-glycine-aspartic acid dependent manner. In addition, this OPN-mediated cellular adhesion was completely blocked with an anti-alphavbeta3 integrin antibody (LM609), confirming that only the alphavbeta3 integrin mediated this cellular adhesion. These data demonstrate that, at least among the alphav integrins, only the alphavbeta3 is able to support cellular adhesion to osteopontin. This finding may have implications for the design of therapeutics targeting OPN-integrin interactions.
authors.affiliation: Department of Bone Metabolism and Osteoporosis Research, Wyeth-Ayerst Research, Philadelphia 19101, USA. Stephen_Caltabiano-1@sbphrd.com
authors.forename: S
authors.initials: S
authors.lastname: Caltabiano
authors.forename: W T
authors.initials: WT
authors.lastname: Hum
authors.forename: G J
authors.initials: GJ
authors.lastname: Attwell
authors.forename: D N
authors.initials: DN
authors.lastname: Gralnick
authors.forename: L J
authors.initials: LJ
authors.lastname: Budman
authors.forename: A M
authors.initials: AM
authors.lastname: Cannistraci
authors.forename: F J
authors.initials: FJ
authors.lastname: Bex
mesh_terms: D002448:Cell Adhesion / Q000187:drug effects*; D002460:Cell Line; D005109:Extracellular Matrix / Q000502:physiology; D019073:HT29 Cells; D006801:Humans; D009842:Oligopeptides / Q000502:physiology; D053495:Osteopontin; D011487:Protein Conformation; D019030:Receptors, Vitronectin / Q000096:biosynthesis / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology; D012795:Sialoglycoproteins / Q000378:metabolism / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D009842:Oligopeptides; D019030:Receptors, Vitronectin; D011994:Recombinant Proteins; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; D053495:Osteopontin; C047981:arginyl-glycyl-aspartic acid